News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Kosmos Energy’s 29.1% return over the past six months has outpaced the S&P 500 by 15.8%, and its stock price has climbed to $2.99 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
The 10-year Treasury yield briefly rose past 5% on Monday, breaching the threshold for the first time since October.
The 10-year Treasury yield rose past 5% on Monday, breaching the threshold for the first time since October.
The 10-year Treasury yield rose toward the 5% level on Monday.
Royal Caribbean offers accelerating earnings and unusual forward visibility, while Walmart offers defensive scale and e-commerce momentum.
Qualcomm stock has underperformed the market over the past year, but a deal with Amazon could give it a much-needed boost.
Fluor (NYSE:FLR) shares rose 6. 1% in pre-market trading to $57.
IBKR's global expansion, 35% account growth and scalable tech support its outlook, though a 30.22X forward P/E raises valuation risk. Is now the time to buy it?
Honeywell Aerospace has too much upside at its current price not to invest in the stock.
Alphabet is signing contracts for nuclear reactors, suspending buybacks, and doubling its debt load, and one investor sees all of that spending as the most bullish signal in the entire position.
Inspired has gotten torched over the last six months - since March 2026, its stock price has dropped 25.3% to $5.10 per share. This may have investors wondering how to approach the situation.
According to TheFly, Wolfe Research turned more constructive on Affirm after its fiscal fourth-quarter results, arguing that the company’s valuation has become more compelling.
Dutch Bros has the brand momentum and the growth trajectory. Uber has the global scale, the free cash flow, and the autonomous vehicle partnerships.
AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) experimental breast cancer drug camizestrant has failed a late-stage trial, though analysts at Citi say the setback does little to dent the company's prospects. Citi kept its 'buy' rating and £178 target price on the FTSE 100 pharmaceuticals group,...
President Donald Trump‘s nominee for Surgeon General, Dr. Nicole Saphier, disclosed investments in Philip Morris International Inc. (NYSE:PM) and several major beverage and pharmaceutical companies, and agreed to divest from most of them if confirmed for the role. Offloads Tobacco...
Oracle's strong Q1 results and AI-driven cloud growth could boost its ETF appeal. Explore Oracle-heavy ETFs for potential gains and risks.
CAVA's rapid expansion and surging traffic put it in a different growth category than Chewy's steady but modest pet retail business. But is the premium price tag worth it?
Investing.com - U.S. stock index futures fell sharply on Monday, with technology stocks under pressure after several leading artificial intelligence executives called for a slower pace of AI development amid concerns over potential risks from the technology.
Over the last six months, AT&T’s shares have sunk to $26.05, producing a disappointing 6.1% loss - a stark contrast to the S&P 500’s 13.3% gain. This may have investors wondering how to approach the situation.
CrowdStrike commands a premium valuation that its growth and free cash flow continue to justify. UiPath just turned consistently profitable but is still working to convince investors that the growth story is intact.
Kraken Robotics is far from being a household name, and that's part of what gives the stock intriguing potential.
Rockwell Automation has outperformed the broader S&P 500 Index over the past year, although analysts remain cautiously optimistic about the company’s outlook.
The market didn't reward Broadcom's latest quarterly report with big stock gains, but the business's outlook remains promising.
One is the fastest-growing connectivity play in AI infrastructure. The other has Nvidia's backing and a decade of hyperscaler relationships. Which belongs in your portfolio?
The market's go-to fear gauge was surging on Monday after three major AI CEOs caused for a slowdown in the development of artificial intelligence, which dragged down chip and memory stocks. The Cboe Volatility Index, or VIX, jumped by almost 2 points to just under 18 in early trading.
Intuit (NASDAQ:INTU) shares rose nearly 2% in pre-market trading to $327. 80, outperforming broader US equity indices during a weaker session for technology stocks.
Atlassian (NASDAQ:TEAM) shares rose 3% in pre-market trading on Monday to $185. 12 as US software stocks moved higher while semiconductor and other AI-linked shares declined.